LYMPHOCYTIC OESOPHAGITIS

LYMPHOCYTIC OESOPHAGITIS was reported 47 times

LYMPHOCYTIC OESOPHAGITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 GLP-2 Analog [EPC] 1 0.0001
1 Stimulant Laxative [EPC] 1 0.0001
2 Provitamin D2 Compound [EPC] 2 0.0001
3 Programmed Death Receptor-1 Blocking Antibody [EPC] 6 0.0001
4 Aluminum Complex [EPC] 1 0.0000
5 Ester Local Anesthetic [EPC] 2 0.0000
6 Integrin Receptor Antagonist [EPC] 3 0.0000
7 Methylxanthine [EPC] 2 0.0000
8 Tetracycline-class Drug [EPC] 2 0.0000
9 Non-Standardized Chemical Allergen [EPC] 2 0.0000
10 Amide Local Anesthetic [EPC] 2 0.0000
11 Central Nervous System Stimulant [EPC] 2 0.0000
12 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
13 Antiarrhythmic [EPC] 2 0.0000
14 Nitroimidazole Antimicrobial [EPC] 1 0.0000
15 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
16 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
17 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
18 Purine Antimetabolite [EPC] 1 0.0000
19 Aminosalicylate [EPC] 1 0.0000
20 Interleukin-12 Antagonist [EPC] 1 0.0000
21 Interleukin-23 Antagonist [EPC] 1 0.0000
22 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
23 Proton Pump Inhibitor [EPC] 5 0.0000
24 Alkylating Drug [EPC] 2 0.0000
25 Osmotic Laxative [EPC] 2 0.0000
26 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
27 Janus Kinase Inhibitor [EPC] 1 0.0000
28 Microtubule Inhibitor [EPC] 1 0.0000
29 Benzodiazepine [EPC] 4 0.0000
30 Platelet Aggregation Inhibitor [EPC] 3 0.0000
31 Tumor Necrosis Factor Blocker [EPC] 5 0.0000
32 Corticosteroid [EPC] 6 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
34 Opioid Agonist [EPC] 1 0.0000
35 Platinum-based Drug [EPC] 1 0.0000
36 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
37 Factor Xa Inhibitor [EPC] 1 0.0000
38 Vitamin D [EPC] 1 0.0000
39 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
40 Vitamin B12 [EPC] 1 0.0000
41 Vitamin C [EPC] 1 0.0000